NEW YORK--(BUSINESS WIRE)--Oct 20, 2023--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved PENBRAYA鈩� (meningococcal groups A, B, C, W and Y vaccine), the first and only pentavalent vaccine that provides coverage against the most common ...
CVS Health is pulling from its shelves some cough-and-cold treatments that contain an ingredient that has been <a href="https://apnews.com/article/sudafed-decongestants-phenylephrine-pseudoephedrine-fda-0f140bafae9a500c5fba05fe764ecb66">deemed ineffective</a> by ...
DUBLIN--(BUSINESS WIRE)--Oct 20, 2023--The <a ...
RICHMOND, Va.--(BUSINESS WIRE)--Oct 19, 2023--Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, today announced it has entered into a drug development collaboration with the University of Virginia (UVA) to advance novel inhaled-drug candidates ...
LILLE, France--(BUSINESS WIRE)--Oct 19, 2023--4Moving Biotech, a spin-off of 4P-Pharma dedicated to facing the global challenge of knee osteoarthritis, announces that it has reached a significant milestone by completing patient recruitment for its LASARE Phase I clinical trial.This press ...
HORGEN, Switzerland--(BUSINESS WIRE)--Oct 19, 2023--<a ...
